Perioperative pharmacology: pharmacotherapeutics, pharmacokinetics, and pharmacodynamics.
Summary of "Perioperative pharmacology: pharmacotherapeutics, pharmacokinetics, and pharmacodynamics."
Results of current research into perioperative medication errors have revealed that more than half of medication errors occur during the administration phase of the medication-use process. The administration phase is the point at which the medication and the patient intersect and the medication imposes its pharmacological effect. During this phase, the only safety net between the patient and the medication is the health care provider's attention and care when administering the medication. To help mitigate these errors, perioperative nurses must understand pharmacotherapeutics: the use of medications to prevent, treat, cure, or alleviate symptoms of disease. Pharmacotherapeutics incorporates pharmacokinetics (ie, what the body does to a medication after it enters the system) and pharmacodynamics (ie, how a medication acts on the body to achieve a desired therapeutic effect).
Affiliation
Journal Details
This article was published in the following journal.
Name: AORN journal
ISSN: 1878-0369
Pages: 259-69
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21281769
- DOI: http://dx.doi.org/10.1016/j.aorn.2010.08.024
Medical and Biotech [MESH] Definitions
Pharmacology, Clinical
The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.
Perioperative Period
The time periods immediately before, during and following a surgical operation.
Perioperative Nursing
Nursing care of the surgical patient before, during, and after surgery.
Perioperative Care
Interventions to provide care prior to, during, and immediately after surgery.
Adjuvants, Pharmaceutic
Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.
PubMed Articles
Avagacestat is an orally active γ-secretase inhibitor that selectively inhibits amyloid β (Aβ) synthesis in cell culture and animal models. The objective of the current study was to assess the phar...
An understanding of the basic principles of pharmacokinetics and pharmacodynamics of drugs is important in appropriate therapeutic use of various drugs. In simple terms, the effects of the body on the...
Safety of perioperative β-blocker use: how do β-blockers compare in terms of side effects?
Introduction: In the perioperative setting, there is still a high incidence of adverse cardiac events due to sudden coronary plaque rupture or oxygen supply-demand imbalance. β-Blockers play an impor...
Objective: To assess the effects of meal timing on the pharmacokinetics and pharmacodynamics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin in Japanese patients with Type 2 diabetes. Me...
Clinical Trials
Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029
This is a multiple dose study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of an investigational new drug.
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
The purpose of this study is to examine the pharmacokinetics, pharmacodynamics, and pharmacogenomics of dexmedetomidine in the following three pediatric patient populations: patients with...
OPC-41061 at 3.75 mg/day or 7.5 mg/day will be orally administered once daily for 7 days to cirrhosis patients with ascites despite having received treatment with conventional diuretics an...
Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide
The aims of this study were to investigate the effects of CYP2C9 and CYP2C19 polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in healthy Chinese subjects.
Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
To investigate the safety, tolerance, pharmacokinetics and pharmacodynamics of tolvaptan 15, 30 and 60 mg after single oral administration in healthy Korean male subjects.
